Schizophrenia Spectrum: Clinical Trials

1 trial for Schizophrenia Spectrum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Schizophrenia Spectrum: new trials by email Literature Review of Schizophrenia Spectrum trials Research Report on Schizophrenia Spectrum

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Relative Bioavailability of LY03010 Compared to Listed Drug
LY03010; paliperidone palmitate, INVEGA SUSTENNA - Schizophrenia, Psychotic Disorders
Phase 1CompletedLuye Pharma Group Ltd.2812021-01-132023-04-25

Narrower conditions

Mental Disorders (1)  ·  Mood Disorders (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)

Broader conditions

Schizophrenia Spectrum and Other Psychotic Disorders (1)

Interventions

Paliperidone Palmitate (1)

Sponsors

Luye Pharma Group Ltd. (1)

Countries

United States (1)

Top investigators

Rui Li, MD (1)

Results publications

PMID 42752599